Asperuloside

Asperuloside at a Glance

Asperuloside is an iridoid glycoside — a bitter monoterpene glucoside — and the single most characteristic iridoid of the Rubiaceae, the coffee/madder family. It recurs across the database as the marker compound of cleavers (Galium aparine) and its bedstraw relatives, of sweet woodruff (Galium odoratum), of Eucommia ulmoides leaf, and of noni (Morinda citrifolia) fruit ^{1,2Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →}.

Its evidence is entirely preclinical but reasonably developed for an iridoid. The best-worked signal is metabolic / anti-obesity — isolated asperuloside improves body weight, glucose and lipid handling in high-fat-fed rats, partly by reshaping the gut microbiota ^{5,6Reference 5Fujikawa T et al. · 2012AnimalAsperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activityView study →Reference 6Nakamura A et al. · 2020Asperuloside improves obesity and type 2 diabetes through modulation of gut microbiota and metabolic signaling. iScience. https://pubmed.ncbi.nlm.nih.gov/32932138/View study →}. On top of that sits a shared anti-inflammatory mechanism (suppression of NF-κB and MAPK signalling) ^{3,4Reference 3He J et al. · 2018Asperuloside and asperulosidic acid exert an anti-inflammatory effect via suppression of the NF-κB and MAPK signaling pathways in LPS-induced RAW 264.7 macrophagesView study →Reference 4Jaafar A et al. · 2024In vitroTherapeutic potentials of iridoids derived from Rubiaceae against in vitro and in vivo inflammation: a scoping reviewView study →} and a growing hepatoprotective / anti-fibrotic thread ^{10,11Reference 10Wang Y et al. · 2025Asperuloside, an iridoid glycoside found in Rubiaceae plants, for attenuating fibrogenesis and inflammation in hepatic fibrosisView study →Reference 11Huang H et al. · 2026The protective effect of asperuloside on liver injury: insights from metabolomics and the mTOR-mediated autophagy perspectiveView study →}.

Two disciplines are load-bearing throughout. First, the human antihypertensive reputation belongs to whole Eucommia-leaf extract, not to isolated asperuloside ^{7Reference 7Nishibe S et al. · 2023AnimalThe differences of mechanisms in antihypertensive and anti-obesity effects of Eucommia leaf extract between rodents and humansView study →} — a marker-vs-agent distinction it shares with its sibling iridoid aucubin. Second, like most iridoid glucosides it is poorly absorbed orally and hydrolysed in the gut to its acid derivatives (asperulosidic acid and deacetylasperulosidic acid) and a reactive aglycone, so in-vitro potency overreads what an oral dose delivers ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →}.

The Rubiaceae Marker Iridoid

If a plant is in the coffee family and tastes bitter, asperuloside is a good bet for why. It is the chemotaxonomic signature iridoid of the Rubiaceae, distributed across Galium (cleavers, woodruff, the bedstraws), Eucommia, Morinda (noni), Hedyotis/Oldenlandia, Paederia and their madder-family relatives, where it functions as the bitter, cooling principle of the traditional preparations ^{1,2Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →}. The two named pharmacological signals that travel with it across these plants are anti-inflammatory activity and an antihypertensive / anti-obesity metabolic effect — both discussed in full below, and both stronger for the isolated molecule in cell and rodent work than in any human isolate study ^{1,3,5Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 3He J et al. · 2018Asperuloside and asperulosidic acid exert an anti-inflammatory effect via suppression of the NF-κB and MAPK signaling pathways in LPS-induced RAW 264.7 macrophagesView study →Reference 5Fujikawa T et al. · 2012AnimalAsperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activityView study →}.

The wilting-woodruff smell is a separate molecule — and worth getting right. Sweet woodruff is famous for the “fresh hay” or new-mown-grass scent it releases as it wilts and dries (the aroma of German Maiwein/May wine). That fragrance is coumarin, not asperuloside. In the living plant the coumarin is stored as a non-volatile, odourless bound glycoside; enzymatic hydrolysis on wilting and drying liberates free coumarin, which is what you smell — a process characterised in detail during woodruff drying ^{12Reference 12Herre I et al. · 2025Comprehensive analysis of natural products of Galium odoratum (Rubiaceae), focusing on the formation of coumarin during the drying processView study →}. Asperuloside co-occurs in the same tissue as the bitter iridoid marker; it is itself essentially odourless and bitter, and is a different compound on a different biosynthetic route from the coumarin aroma. The two are easy to conflate because they share the plant and both depend on glycoside hydrolysis — but the smell is coumarin’s, and the bitterness (and the pharmacology here) is asperuloside’s.

Asperuloside & Its Acid Derivatives

Asperuloside sits at the head of a small, closely-related family of Rubiaceae iridoids that are constantly interconverted by simple deacetylation and ester hydrolysis — and keeping them straight matters, because the literature often tests one and generalises to the group.

• Asperuloside — the parent, an acetylated iridoid glucoside.
• Asperulosidic acid — asperuloside with the lactone/methyl-ester arrangement opened to the free carboxylic acid; a co-occurring bedstraw iridoid and the form carrying much of the anticancer data (see below).
• Deacetylasperulosidic acid — the de-acetylated acid, one of the main downstream forms and a common circulating/urinary metabolite of dietary iridoids; noni’s principal iridoid is this compound.

In cleavers and other Galium these appear together — the herb-extraction record for cleavers lists asperuloside, asperulosidic acid, deacetylasperulosidic acid and 10-desacetylasperulosidic acid side by side as the bitter cooling iridoids ^{14Reference 14Ilina T et al. · 2019In vitroPhytochemical profiles and in vitro immunomodulatory activity of ethanolic extracts from Galium aparine LView study →}. The practical consequences are two. First, on hydrolysis (gut β-glucosidase, or acid/enzyme during processing) asperuloside loses its acetyl and sugar groups, so what reaches the circulation after an oral dose is largely the deacetylated acids and aglycone, not intact asperuloside. Second, some of the headline “asperuloside-family” bioactivity is really its derivative’s: the strongest anticancer finding is for asperulosidic acid, which restrained hepatocellular-carcinoma cells and enhanced chemosensitivity by inactivating the MEKK1/NF-κB pathway ^{9Reference 9Li L et al. · 2024Asperulosidic acid restrains hepatocellular carcinoma development and enhances chemosensitivity through inactivating the MEKK1/NF-κB pathwayView study →} — a result for the acid, not the parent acetate. This page keeps asperuloside itself in focus and flags where a claim actually rests on a derivative. (Dedicated pages for asperulosidic acid, deacetylasperulosidic acid and the related Rubiaceae iridoid monotropein are not yet built.)

What It's Used For

Asperuloside’s profile is preclinical but multi-organ, and unusually weighted toward metabolic endpoints for an iridoid. The load-bearing caveat is the compound-page discipline: no human isolate trials, the human antihypertensive data are a whole Eucommia extract ^{7Reference 7Nishibe S et al. · 2023AnimalThe differences of mechanisms in antihypertensive and anti-obesity effects of Eucommia leaf extract between rodents and humansView study →}, and its poor absorption / gut hydrolysis ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →} limit how far in-vitro potency translates.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. No human isolate data exist, so scores stay modest by design; the antihypertensive row rests on a whole extract.

01Anti-obesity / metabolicShaky44%Isolate in high-fat-fed rats + gut-microbiota mechanism ^{5,6Reference 5Fujikawa T et al. · 2012AnimalAsperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activityView study →Reference 6Nakamura A et al. · 2020Asperuloside improves obesity and type 2 diabetes through modulation of gut microbiota and metabolic signaling. iScience. https://pubmed.ncbi.nlm.nih.gov/32932138/View study →}

02Anti-inflammatoryShaky40%Isolate ↓NF-κB/MAPK, NO/PGE₂/TNF-α/IL-6 in macrophages + Rubiaceae-iridoid review ^{3,4Reference 3He J et al. · 2018Asperuloside and asperulosidic acid exert an anti-inflammatory effect via suppression of the NF-κB and MAPK signaling pathways in LPS-induced RAW 264.7 macrophagesView study →Reference 4Jaafar A et al. · 2024In vitroTherapeutic potentials of iridoids derived from Rubiaceae against in vitro and in vivo inflammation: a scoping reviewView study →}

03Hepatoprotective / anti-fibroticShaky34%Isolate in hepatic fibrosis (SIRT6/TLR) + liver-injury autophagy (mTOR) ^{10,11Reference 10Wang Y et al. · 2025Asperuloside, an iridoid glycoside found in Rubiaceae plants, for attenuating fibrogenesis and inflammation in hepatic fibrosisView study →Reference 11Huang H et al. · 2026The protective effect of asperuloside on liver injury: insights from metabolomics and the mTOR-mediated autophagy perspectiveView study →}

04Antioxidant / organ protectionShaky28%Isolate ↓cadmium-induced oxidative stress/fibrosis/apoptosis in rats ^{8Reference 8Kong Z et al. · 2023AnimalAsperuloside attenuates cadmium-induced toxicity by inhibiting oxidative stress, inflammation, fibrosis and apoptosis in ratsView study →}

05Antihypertensive (whole extract)Shaky22%Traditional + regulatory use of whole Eucommia-leaf extract, not the isolate ^{2,7Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →Reference 7Nishibe S et al. · 2023AnimalThe differences of mechanisms in antihypertensive and anti-obesity effects of Eucommia leaf extract between rodents and humansView study →}

Mechanisms

The load-bearing, most-reproduced findings are the metabolic (rat, isolate) and anti-inflammatory (NF-κB/MAPK) signals; the liver, antioxidant and antihypertensive rows are single- or few-study extensions of that same anti-inflammatory/antioxidant core, and the antihypertensive one is a whole-extract property.

Pharmacokinetics

Asperuloside behaves as a typical poorly-absorbed iridoid glucoside. Its polar, glycosylated structure gives low membrane permeability, and — like related iridoids — it is hydrolysed in the gastrointestinal tract by β-glucosidase and esterases, losing its acetyl and sugar groups to yield deacetylasperulosidic acid, asperulosidic acid and a reactive aglycone ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →}. The practical reading is that intact asperuloside reaching the systemic circulation after an oral dose is low, and much of what is measured downstream is its acid metabolites; robust isolate ADME numbers (Cmax, half-life, absolute oral bioavailability) for asperuloside itself are not well established ^{1,2Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →}. This has two consequences the page leans on: the reported anti-obesity effect is partly gut-mediated (microbiota remodelling), consistent with a compound acting substantially before absorption ^{6Reference 6Nakamura A et al. · 2020Asperuloside improves obesity and type 2 diabetes through modulation of gut microbiota and metabolic signaling. iScience. https://pubmed.ncbi.nlm.nih.gov/32932138/View study →}; and the gap between micromolar in-vitro potency and an achievable oral exposure is real, so cell-assay effect sizes should not be read as human doses.

Clinical Trials

There are no clinical trials of isolated asperuloside — the systematic review is explicit that despite its breadth of preclinical activity, no clinical trial has been performed ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →}. The nearest human/real-world footprint is whole Eucommia-leaf extract: a traditional hypotensive medicine and, as Tochu-cha, a government-approved food for high blood pressure in Japan — a whole-extract exposure in which asperuloside is one implicated iridoid among several, not the tested agent ^{2,7Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →Reference 7Nishibe S et al. · 2023AnimalThe differences of mechanisms in antihypertensive and anti-obesity effects of Eucommia leaf extract between rodents and humansView study →}.

Last checked: July 2026.

Isolate vs. Plant Studies

The split here is comparatively favourable on the mechanism side and honest on the human side. The metabolic, anti-inflammatory, hepatoprotective and antioxidant work is largely done with the isolated molecule in rats and cell lines ^{3,5,6,8,11,14Reference 3He J et al. · 2018Asperuloside and asperulosidic acid exert an anti-inflammatory effect via suppression of the NF-κB and MAPK signaling pathways in LPS-induced RAW 264.7 macrophagesView study →Reference 5Fujikawa T et al. · 2012AnimalAsperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activityView study →Reference 6Nakamura A et al. · 2020Asperuloside improves obesity and type 2 diabetes through modulation of gut microbiota and metabolic signaling. iScience. https://pubmed.ncbi.nlm.nih.gov/32932138/View study →Reference 8Kong Z et al. · 2023AnimalAsperuloside attenuates cadmium-induced toxicity by inhibiting oxidative stress, inflammation, fibrosis and apoptosis in ratsView study →Reference 11Huang H et al. · 2026The protective effect of asperuloside on liver injury: insights from metabolomics and the mTOR-mediated autophagy perspectiveView study →Reference 14Ilina T et al. · 2019In vitroPhytochemical profiles and in vitro immunomodulatory activity of ethanolic extracts from Galium aparine LView study →} — those are asperuloside’s own effects, a genuine strength for an iridoid. The weakness is translational and attributional at the two ends. Translationally, poor absorption and gut hydrolysis ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →} mean isolate potency does not transfer cleanly to an oral human dose, and part of the metabolic benefit is a gut-level effect rather than a systemic drug action ^{6Reference 6Nakamura A et al. · 2020Asperuloside improves obesity and type 2 diabetes through modulation of gut microbiota and metabolic signaling. iScience. https://pubmed.ncbi.nlm.nih.gov/32932138/View study →}. Attributionally, the one place asperuloside touches human evidence — antihypertension — it does so only as a constituent of whole Eucommia-leaf extract, alongside geniposidic acid and other iridoids ^{7Reference 7Nishibe S et al. · 2023AnimalThe differences of mechanisms in antihypertensive and anti-obesity effects of Eucommia leaf extract between rodents and humansView study →}, and the whole-herb anti-inflammatory data for woodruff are credited to the extract’s phenolic fraction, not asperuloside ^{13Reference 13Razzivina V et al. · 2024AnimalPhenolic content and anti-inflammatory activity of cultivated and wild-type Galium odoratum extracts in murine bone marrow-derived macrophagesView study →}. Read asperuloside’s own dossier as the metabolic/anti-inflammatory rodent story; its appearance in Eucommia and woodruff preparations is a whole-plant matter.

Its Role in Plants

In the plant, asperuloside is a defensive iridoid. Iridoid glycosides are bitter, deterrent compounds stored inert as the glucoside; tissue damage brings them into contact with β-glucosidase, releasing a reactive aglycone that deters and can harm herbivores and pathogens — the same enzyme-triggered activation that governs its pharmacokinetics ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →}. Its concentration in the bitter aerial parts and leaves of Rubiaceae is consistent with this chemical-defence role, and its taxonomic constancy makes it a chemotaxonomic marker for the family and for the Galium genus in particular ^{2Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →}.

A related but distinct piece of plant chemistry runs alongside it in sweet woodruff: the plant’s coumarin — the source of the wilting “fresh hay” aroma — is likewise stored as an odourless bound glycoside and freed by hydrolysis when the tissue is damaged or dried ^{12Reference 12Herre I et al. · 2025Comprehensive analysis of natural products of Galium odoratum (Rubiaceae), focusing on the formation of coumarin during the drying processView study →}. Asperuloside and the coumarin precursor are different molecules on different pathways that happen to share the same enzyme-triggered “damage-activated” logic. As always, a compound’s defensive role in the plant is plant biology, not human pharmacology, and does not predict what it does as a medicine.

Prevalence in Nature

Asperuloside is one of the defining iridoids of the Rubiaceae and is distributed across many of the family’s genera ^{1,2Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →}. Documented sources include:

• Bedstraws and cleavers (Galium spp.) — cleavers (Galium aparine) aerial parts carry it alongside asperulosidic acid, deacetylasperulosidic acid and 10-desacetylasperulosidic acid as the bitter cooling iridoids ^{14Reference 14Ilina T et al. · 2019In vitroPhytochemical profiles and in vitro immunomodulatory activity of ethanolic extracts from Galium aparine LView study →};
• Sweet woodruff (Galium odoratum) — the namesake source (the old genus name Asperula gives the compound its name), where it co-occurs with the coumarin responsible for the aroma ^{12Reference 12Herre I et al. · 2025Comprehensive analysis of natural products of Galium odoratum (Rubiaceae), focusing on the formation of coumarin during the drying processView study →};
• Eucommia (Eucommia ulmoides) leaf — a well-studied source used in the anti-obesity/antihypertensive work ^{5,7Reference 5Fujikawa T et al. · 2012AnimalAsperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activityView study →Reference 7Nishibe S et al. · 2023AnimalThe differences of mechanisms in antihypertensive and anti-obesity effects of Eucommia leaf extract between rodents and humansView study →};
• Noni (Morinda citrifolia) fruit — a Rubiaceae food source in which iridoids of this family (chiefly the deacetylated acid) are characteristic;
• Hedyotis / Oldenlandia, Paederia and other madder-family (Rubiaceae) relatives ^{4Reference 4Jaafar A et al. · 2024In vitroTherapeutic potentials of iridoids derived from Rubiaceae against in vitro and in vivo inflammation: a scoping reviewView study →}.

Its absolute content is rarely reported as a reliable % dry weight and varies widely with species, plant part and provenance, so no dependable cross-source concentration ranking exists — a gap tracked for a later pass rather than asserted here. Biosynthetically it belongs to the iridoid pathway (geraniol → 8-oxogeranial → iridodial via iridoid synthase, then oxidation, esterification and glucosylation), the same route that produces its sibling iridoids aucubin and harpagide.

Discovery & Synthesis

Asperuloside was first isolated in the nineteenth century from woodruff, then classified as Asperula odorata (now Galium odoratum) — the genus name is the origin of the compound’s name, and the old synonym rubichloric acid survives from that early work. As with most abundant plant iridoids, characterisation of its structure as an acetylated iridoid glucoside was the work of nineteenth- and twentieth-century natural-product chemistry, and the compound is a standard chemotaxonomic marker of the Rubiaceae ^{1,2Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →}.

Total synthesis of asperuloside is not well documented and is not the source of supply: the molecule is abundant in nature and its reactive, hydrolysis-prone chemistry makes synthesis unattractive versus extraction from iridoid-rich Rubiaceae (notably Eucommia leaf and Galium aerial parts). Commercial and research supply is therefore by isolation, not manufacture.

Patents: not yet researched.

Toxicity & Safety

Asperuloside reads as a low-toxicity, food-and-medicine-adjacent Rubiaceae iridoid. It occurs in materials with a long dietary/medicinal history — Eucommia-leaf tea is an approved food in Japan ^{7Reference 7Nishibe S et al. · 2023AnimalThe differences of mechanisms in antihypertensive and anti-obesity effects of Eucommia leaf extract between rodents and humansView study →}, noni fruit is eaten, and cleavers and woodruff have long traditional use — and the systematic reviews characterise its toxicity as low, with rodent efficacy studies (including a protective role against cadmium toxicity) reporting no acute toxicity signal at the doses used ^{1,2,8Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →Reference 8Kong Z et al. · 2023AnimalAsperuloside attenuates cadmium-induced toxicity by inhibiting oxidative stress, inflammation, fibrosis and apoptosis in ratsView study →}. The rating stays at low, with honest, chemistry-driven caveats rather than observed harms.

Safety at a Glance

✅ Low / no toxicity

• A widespread dietary/medicinal plant iridoid. Present in eaten and long-used Rubiaceae (Eucommia-leaf tea, noni fruit, cleavers, woodruff) with no acute toxicity signal at the doses used in rodent studies ^{1,2Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →}.
• Poorly absorbed and gut-metabolised. Low systemic exposure of the intact molecule limits the scope for systemic isolate toxicity ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →}.
• Hydrolysis releases a reactive aglycone. Like other iridoid glucosides, β-glucosidase cleavage yields a reactive aglycone — a chemistry caveat behind treating high-dose/aglycone exposure cautiously ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →}.
• No comprehensive isolate toxicology. No definitive LD50, genotoxicity or repeat-dose package for the pure compound; reproductive safety of the isolate is not established.
• Woodruff’s coumarin is a separate consideration. In sweet woodruff the co-occurring coumarin (not asperuloside) carries its own dose-dependent cautions — a whole-herb issue that belongs to the woodruff page, not to this molecule.

Full Safety & Interactions Detail

Asperuloside carries a low flag. It is a natural Rubiaceae iridoid glycoside of foods and traditional medicines with no acute toxicity signal in the rodent studies available, and reviews characterise its toxicity profile as low ^{1,2Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →Reference 2Chan Y et al. · 2020Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanismsView study →}.

Indeed one rat study reports it protecting against cadmium-induced organ toxicity ^{8Reference 8Kong Z et al. · 2023AnimalAsperuloside attenuates cadmium-induced toxicity by inhibiting oxidative stress, inflammation, fibrosis and apoptosis in ratsView study →}.

The caveats are chemical and evidentiary rather than documented harms. First, as an iridoid glucoside it is hydrolysed by β-glucosidase to a reactive aglycone (and its deacetylated acid metabolites) — the standard iridoid-class reason to treat high-dose or aglycone exposure cautiously, though poor oral absorption limits real-world isolate exposure ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →}.

Second, there is no comprehensive isolate toxicology — no definitive LD50, genotoxicity or repeat-dose organ-toxicity package — and no reproductive-safety data for pure asperuloside; any pregnancy/lactation caution around asperuloside-containing herbs (cleavers, woodruff, Eucommia, noni) is a per-herb decision that belongs on the source-herb or product page where intake is decided, not on this molecule page. Finally, the safety story of sweet woodruff specifically is dominated by its coumarin content, not asperuloside: coumarin has its own dose-dependent hepatic cautions and is the reason woodruff is used sparingly — a whole-herb consideration distinct from the iridoid discussed here ^{12Reference 12Herre I et al. · 2025Comprehensive analysis of natural products of Galium odoratum (Rubiaceae), focusing on the formation of coumarin during the drying processView study →}.

No isolate drug-interaction data (CYP/transporter) are characterised for asperuloside.

Dosage

There is no established or recommended human dose for isolated asperuloside — it has never been given to people as a purified drug. Cited figures are preclinical research doses: micromolar concentrations in cell assays, and low-to-mid mg/kg (or, in the anti-obesity work, roughly 1% of a high-fat diet) in rats ^{5,6Reference 5Fujikawa T et al. · 2012AnimalAsperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activityView study →Reference 6Nakamura A et al. · 2020Asperuloside improves obesity and type 2 diabetes through modulation of gut microbiota and metabolic signaling. iScience. https://pubmed.ncbi.nlm.nih.gov/32932138/View study →} — none of which translate to human self-dosing, especially given poor oral absorption and gut hydrolysis ^{1Reference 1Manzione MG et al. · 2020Systematic reviewPhytochemical and pharmacological properties of asperuloside, a systematic reviewView study →}. Real-world human exposure is entirely whole-plant and indirect:

In every case asperuloside is one bitter iridoid among many constituents, standardised (if at all) as a marker rather than dosed as an active. These are doses studied in research and are not a personal recommendation.

References

1. Manzione MG, et al. (2020). Phytochemical and pharmacological properties of asperuloside, a systematic review. European Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/32659300/
2. Chan Y, et al. (2020). Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanisms. Chemico-Biological Interactions. https://pubmed.ncbi.nlm.nih.gov/31786185/
3. He J, et al. (2018). Asperuloside and asperulosidic acid exert an anti-inflammatory effect via suppression of the NF-κB and MAPK signaling pathways in LPS-induced RAW 264.7 macrophages. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/30002289/
4. Jaafar A, et al. (2024). Therapeutic potentials of iridoids derived from Rubiaceae against in vitro and in vivo inflammation: a scoping review. Saudi Pharmaceutical Journal. https://pubmed.ncbi.nlm.nih.gov/38226349/
5. Fujikawa T, et al. (2012). Asperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activity. Journal of Nutritional Science. https://pubmed.ncbi.nlm.nih.gov/25191539/
6. Nakamura A, et al. (2020). Asperuloside improves obesity and type 2 diabetes through modulation of gut microbiota and metabolic signaling. iScience. https://pubmed.ncbi.nlm.nih.gov/32932138/
7. Nishibe S, et al. (2023). The differences of mechanisms in antihypertensive and anti-obesity effects of Eucommia leaf extract between rodents and humans. Molecules. https://pubmed.ncbi.nlm.nih.gov/36838952/
8. Kong Z, et al. (2023). Asperuloside attenuates cadmium-induced toxicity by inhibiting oxidative stress, inflammation, fibrosis and apoptosis in rats. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/37029128/
9. Li L, et al. (2024). Asperulosidic acid restrains hepatocellular carcinoma development and enhances chemosensitivity through inactivating the MEKK1/NF-κB pathway. Applied Biochemistry and Biotechnology. https://pubmed.ncbi.nlm.nih.gov/37097403/
10. Wang Y, et al. (2025). Asperuloside, an iridoid glycoside found in Rubiaceae plants, for attenuating fibrogenesis and inflammation in hepatic fibrosis. Natural Product Research. https://pubmed.ncbi.nlm.nih.gov/41418300/
11. Huang H, et al. (2026). The protective effect of asperuloside on liver injury: insights from metabolomics and the mTOR-mediated autophagy perspective. Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/41187509/
12. Herre I, et al. (2025). Comprehensive analysis of natural products of Galium odoratum (Rubiaceae), focusing on the formation of coumarin during the drying process. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/40122276/
13. Razzivina V, et al. (2024). Phenolic content and anti-inflammatory activity of cultivated and wild-type Galium odoratum extracts in murine bone marrow-derived macrophages. Antioxidants (Basel). https://pubmed.ncbi.nlm.nih.gov/39765776/
14. Ilina T, et al. (2019). Phytochemical profiles and in vitro immunomodulatory activity of ethanolic extracts from Galium aparine L. Plants (Basel). https://pubmed.ncbi.nlm.nih.gov/31775336/

View all 14 references▾